• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧氟沙星在人肺组织中的扩散。 需要说明的是,原文中“Diffusion of ofloxacin into human lung tissue.”多了一个“of”,正确表述应该是“Diffusion of ofloxacin into human lung tissue” 。

Diffusion of ofloxacin into human lung tissue.

作者信息

Couraud L, Fourtillan J B, Saux M C, Bryskier A, Vincent du Laurier M

机构信息

Thoracic Surgery Unit, Hôpital Xavier Arnozan, Pessac.

出版信息

Drugs. 1987;34 Suppl 1:37-8. doi: 10.2165/00003495-198700341-00009.

DOI:10.2165/00003495-198700341-00009
PMID:3481326
Abstract

Ofloxacin 200mg twice daily was administered to 17 patients with pulmonary disorders, which necessitated surgery, during the preceding 48 hours and 200mg was administered 1 hour before the operation. During surgery, blood samples and specimens of healthy and diseased lung tissues were taken simultaneously. Ofloxacin levels were determined by HPLC. The mean values of the tissue concentration/plasma concentration ratio were 3.5 +/- 0.4 for the healthy tissue and 3.9 +/- 0.4 for the diseased tissue. These values reflected good penetration of ofloxacin into both healthy and atelectasic pulmonary parenchyma.

摘要

在手术前48小时,给17名患有肺部疾病且需要进行手术的患者每日两次服用200毫克氧氟沙星,并在手术前1小时服用200毫克。手术期间,同时采集血样以及健康和患病肺组织的标本。通过高效液相色谱法测定氧氟沙星水平。健康组织的组织浓度/血浆浓度比值的平均值为3.5±0.4,患病组织为3.9±0.4。这些数值反映出氧氟沙星在健康和肺不张的肺实质中均有良好的渗透。

相似文献

1
Diffusion of ofloxacin into human lung tissue.氧氟沙星在人肺组织中的扩散。 需要说明的是,原文中“Diffusion of ofloxacin into human lung tissue.”多了一个“of”,正确表述应该是“Diffusion of ofloxacin into human lung tissue” 。
Drugs. 1987;34 Suppl 1:37-8. doi: 10.2165/00003495-198700341-00009.
2
[Diffusion of ofloxacin in human lung tissue].
Infection. 1986;14 Suppl 1:S65-6. doi: 10.1007/BF01645202.
3
Penetration of ofloxacin from blood to sputum.
Drugs. 1987;34 Suppl 1:26-32. doi: 10.2165/00003495-198700341-00007.
4
Pharmacokinetics of ofloxacin in patients on haemodialysis treatment.
Drugs. 1987;34 Suppl 1:62-70. doi: 10.2165/00003495-198700341-00014.
5
Biliary tract excretion of ofloxacin in man.氧氟沙星在人体中的胆道排泄。
Drugs. 1987;34 Suppl 1:39-43. doi: 10.2165/00003495-198700341-00010.
6
A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure.氧氟沙星、去甲基氧氟沙星和氧氟沙星N-氧化物在慢性肾衰竭患者体内的药代动力学初步报告。
Drugs. 1987;34 Suppl 1:56-61. doi: 10.2165/00003495-198700341-00013.
7
Penetration of ofloxacin into bronchial secretions.氧氟沙星在支气管分泌物中的渗透情况。 (注:原文中多了一个of,正确表述应该是Penetration of ofloxacin into bronchial secretions. )
Drugs. 1987;34 Suppl 1:33-6. doi: 10.2165/00003495-198700341-00008.
8
Diffusion of oral ofloxacin (HOE 280) into human prostatic tissue: assessment by an improved high-performance liquid chromatographic method.口服氧氟沙星(HOE 280)在人前列腺组织中的扩散:采用改进的高效液相色谱法进行评估。
Infection. 1986;14 Suppl 4:S263-5. doi: 10.1007/BF01661289.
9
Pharmacokinetics of ofloxacin in healthy subjects and patients with impaired renal function.氧氟沙星在健康受试者和肾功能受损患者中的药代动力学。 (你提供的原文多了一个of,正确的应该是Pharmacokinetics of ofloxacin,我按照正确内容翻译了。)
Drugs. 1987;34 Suppl 1:51-5. doi: 10.2165/00003495-198700341-00012.
10
[Intracamera penetration of ofloxacin in man].
J Fr Ophtalmol. 1987;10(6-7):443-6.

引用本文的文献

1
Penetration of orally administered prulifloxacin into human lung tissue.口服普卢利沙星在人肺组织中的渗透情况。
Clin Pharmacokinet. 2005;44(12):1287-94. doi: 10.2165/00003088-200544120-00007.
2
Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.氟喹诺酮类抗生素。微生物学、药代动力学及临床应用。
Drugs. 1988 Aug;36(2):193-228. doi: 10.2165/00003495-198836020-00004.
3
Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.血清、胆汁及胆囊壁组织中氧氟沙星的术中浓度。

本文引用的文献

1
The pharmacokinetics and tissue penetration of ofloxacin.氧氟沙星的药代动力学和组织穿透性。 (注:原文中多了一个of,正确表述应该是The pharmacokinetics and tissue penetration of ofloxacin )
J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647.
2
Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.氧氟沙星(HOE 280 DL 8280)与萘啶酸类似物的体外和体内抗菌活性比较。
Eur J Clin Microbiol. 1983 Dec;2(6):548-53. doi: 10.1007/BF02016563.
3
[Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment].
Antimicrob Agents Chemother. 1990 Dec;34(12):2354-7. doi: 10.1128/AAC.34.12.2354.
4
Penetration of ofloxacin into human lung tissue following a single oral dose of 200 milligrams.单次口服200毫克氧氟沙星后其在人肺组织中的渗透情况。 (你提供的原文中多了一个of,正确的应该是Penetration of ofloxacin... 这里按照修正后的翻译)
Antimicrob Agents Chemother. 1991 Feb;35(2):380-1. doi: 10.1128/AAC.35.2.380.
5
Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens.
Infection. 1991;19 Suppl 7:S365-71. doi: 10.1007/BF01715829.
6
Ofloxacin penetration into tuberculous pleural effusion.氧氟沙星在结核性胸腔积液中的渗透情况。
Antimicrob Agents Chemother. 1991 Oct;35(10):2159-60. doi: 10.1128/AAC.35.10.2159.
7
Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.氧氟沙星。对其抗菌活性、药理学及治疗用途的重新评估。
Drugs. 1991 Nov;42(5):825-76. doi: 10.2165/00003495-199142050-00008.
8
Ofloxacin clinical pharmacokinetics.氧氟沙星的临床药代动力学。
Clin Pharmacokinet. 1992 Jan;22(1):32-46. doi: 10.2165/00003088-199222010-00004.
[氧氟沙星对医院环境分离细菌活性的多中心研究] (注:原文中多了一个of,正确表述应该是Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment )
Pathol Biol (Paris). 1986 May;34(5):390-8.
4
[Respiratory tract infections--clinical results with ofloxacin].[呼吸道感染——氧氟沙星的临床疗效]
Infection. 1986;14 Suppl 1:S79-81. doi: 10.1007/BF01645206.
5
[Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].氧氟沙星对流感嗜血杆菌、肺炎链球菌和脑膜炎奈瑟菌的作用。与同类分子的比较
Pathol Biol (Paris). 1985 May;33(5):385-8.
6
[New oral quinolone compounds in chronic bronchitis].[慢性支气管炎中的新型口服喹诺酮类化合物]
Infection. 1986;14 Suppl 1:S73-8. doi: 10.1007/BF01645205.